Selected cell receptor genotypes differentially modulate the ABO blood group influence on Factor VIII levels in severe aortic stenosis
Selected cell receptor genotypes differentially modulate the ABO blood group…
Ler MaisAn audit of postpartum thromboprophylaxis practices and outcomes following caesarean delivery
An audit of postpartum thromboprophylaxis practices and outcomes following caesarean…
Ler MaisCost of immune tolerance induction according to its outcome in people with hemophilia A and inhibitors: results from the Co$tIT study
Cost of immune tolerance induction according to its outcome in…
Ler MaisEKITE phase 2: A valuable readily available resource for patient education on thrombosis and warfarin anticoagulation therapy
EKITE phase 2: A valuable readily available resource for patient…
Ler MaisAntiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic with von Willebrand factor-mediated characteristics
Antiplatelet-anticoagulant, APAC, a mimic of endogenous heparin, is an antithrombotic…
Ler MaisSplanchnic vein thrombosis (2003−2022): a Swiss nationwide epidemiological study
Splanchnic vein thrombosis (2003−2022): a Swiss nationwide epidemiological study Silvia…
Ler MaisPhenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data from the Rare Bleeding disorders in the Netherlands study
Phenotype, genotype, and laboratory assessment of congenital fibrinogen disorders: Data…
Ler MaisTrends in Treatment of Severe Haemophilia and Impact on Inhibitor Assessment by the EUHASS Registry
Trends in Treatment of Severe Haemophilia and Impact on Inhibitor…
Ler MaisLoss of von Willebrand factor large multimers in patients undergoing hemodialysis: A single-center, retrospective study
Loss of von Willebrand factor large multimers in patients undergoing…
Ler MaisExtended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism
Extended Reduced-Dose Apixaban for Cancer-Associated Venous Thromboembolism Isabelle Mahé, M.D.,…
Ler Mais